T2D was associated with poorer prognosis among males with localised melanoma, whereas no prognostic impact was observed among females or patients with more advanced disease. These findings indicate the need for closer follow-up of males with early-stage melanoma and T2D, and for further studies to clarify underlying mechanisms and the potential benefits of optimised diabetes management.
Lyngstrand et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: